Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 162   

Articles published

AZN 4,944.56 +92.06 (1.90%)
price chart
Barclays Capital analysts "resoundingly positive" on pharma stocks ...
The number crunchers in the research department at Barclays Capital have initiated coverage of the EU pharma sector with a “resoundingly positive view”.
Analyst Activity – Barclays PLC Initiates Coverage On AstraZeneca plc (NYSE ...
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, ...
AstraZeneca plc 26.3% Potential Upside Indicated by Barclays Capital  DirectorsTalk Interviews
AstraZeneca PLC (LSE:AZN): Set To Experience A Decrease In Earnings?  Simply Wall St
FDA Sends Complete Response Letter To AstraZeneca plc (ADR) (NYSE:AZN ...
AstraZeneca plc (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter ((CRL) from the U.S. Food and Drug Administration for ZS-9 a drug designed to treat hyperkalemia.
AstraZeneca Gives Rejected Drugs a Second Life
CAMBRIDGE, England—AstraZeneca PLC executive Kumar Srinivasan has an unusual job description: He is in charge of rejected drugs.
Form 6-K ASTRAZENECA PLC For: Mar 01
The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC ...
JPMorgan Chase & Co. Reiterates “Neutral” Rating for AstraZeneca plc (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its “neutral” rating restated by equities researchers at JPMorgan Chase & Co.
AstraZeneca plc 19.5% Potential Upside Indicated by Berenberg
AstraZeneca plc using EPIC/TICKER code LON:AZN has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Berenberg.
AstraZeneca PLC (NYSE:AZN) Shows Long Term Growth Rate of 0.077  TopChronicle
AstraZeneca plc: MedImmune and Sanofi Pasteur form alliance to develop and ...
MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, today announced an agreement to develop and commercialise MEDI8897 jointly.
Market Risers: AstraZeneca plc, Babcock International Group PLC, BAE Systems ...
Shares in AstraZeneca plc with ticker code: LON:AZN has stepped up 1.27% or 58.5 points during the course of today's session so far.
AstraZeneca plc's (AZN) Sell Rating Reaffirmed at Shore Capital  The Cerbat Gem
Market Risers: AstraZeneca plc, BAE Systems plc, BT Group plc, Carnival plc
The trading price for AstraZeneca plc ticker lookup code: LON:AZN has gained 1.05% or 48 points during today's session so far.
AstraZeneca plc (AZN) Given a GBX 3900 Price Target by Goldman Sachs Group ...  BNB Daily (blog)
AstraZeneca plc's (AZN) “Neutral” Rating Reiterated at JP Morgan Chase ...  Sports Perspectives